Skip to main content

Advertisement

Table 4 Univariate and multivariate analyses for Breast Cancer specific Survival

From: Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer

Variable Univariate Multivariate
  p-value Hazard Ratio (95% CI) p-value Hazard Ratio (95% CI)
Tumor size 0.01 1.02 (1–1.05)   
T3 vs T1, T2    0.05 6.5 (0.99–42.58)
Lymph nodes 0.004 1.08 (1.02–1.15)   
≥ 3 vs < 3    0.77 1.19 (0.35–4.02)
Age categories 0.29 1.64 (0.64–4.18)   
≥ 50 years vs < 50 years    0.04 3.63 (1.04–12.6)
Histological Type 0.14 1.05 (0.72–1.25)   
Ductal vs others    0.96 1.65 (0.3–4.56)
Histological grade 0.85 1.04 (0.53–2.03)   
SBRII vs I    0.68 0.69 (0.12–3.97)
SBRIII vs I    0.57 0.57 (0.08–3.83)
uPA High vs Low 0.02 1.11 (1.01–1.23) 0.13 2.57 (0.74–8.9)
PAI-1 High vs Low <0.0001 7.61 (2.55–22.71) 0.0003 13.17 (3.26–53.17)
  1. Abbreviations: SBR, Scarff Bloom and Richardson.